Every 3^rd asthma patient on inhaled therapy remains uncontrolled¹

 

of patients with asthma remain uncontrolled, despite current treatment with inhaled therapies.*1

Furthermore, of patients are unable to use their inhaler properly, even with training.**2

 

Persistence of symptoms put patients at a higher risk of asthma attacks.³

 

---

Unlock the potential of inhaled asthma care with the ENERZAIR^® BREEZHALER^® family

With once-daily ENERZAIR^® BREEZHALER^®,⁴ your patients can live and breathe every moment.

 

 

---

The ENERZAIR^® BREEZHALER^® device provides certainty that the full dose has been taken

 

 

---

How to use ENERZAIR^® BREEZHALER^®

Watch the following video to learn how to use ENERZAIR® BREEZHALER®

---

Further Information

Click here to learn more about the unmet needs of patients with asthma.

Click here to find out more about the iridium study.

To learn more about Sensor for the ENERZAIR^® BREEZHALER^® device, click here .

 

^*Baseline data from a retrospective study of 45,804 adult asthma patients in the UK, newly initiated on medium- or high-dose LABA/ICS therapy.¹

^**96 pharmacies collected data from 570 adult asthma patients in Australia. Of these, 348 patients were taking preventer/combination medication on a regular basis and were included. All patients who demonstrated incorrect technique at Visit 1 were trained to mastery. Of these, data was available for 238 at follow-up visit.²

^†The Propeller® Sensor for the BREEZHALER^® device (hereinafter referred to as “the Sensor/the Sensor for the BREEZHALER® device”) and the Propeller^® mobile app (hereinafter referred to as “the app“) are the property of Propeller Health^®.

^‡Data derived from studies in COPD patients.^7,8

^§Compared to Diskus^®, HandiHaler^®, Respimat^® and Turbohaler^®.⁷

^¶Compared to Ellipta^® and HandiHaler^®.⁸

 

REFERENCES:

1. Buhl R, et al. Respir Med. 2020;162:105859 [Epub ahead of print].

2. Azzi E, et al. NPJ Prim Care Respir Med. 2017;27:29.

3. GINA Global Strategy for Asthma Management and Prevention. 2019 Update. Available at: https://ginasthma.org/wp-content/ uploads/2019/06/ GINA-2019-main-report-June-2019-wms.pdf . Accessed: February 2020.

4. ENERZAIR^® BREEZHALER^®. Summary of Product Characteristics. July, 2020 for Atectura.

5. ATECTURA^® BREEZHALER^®. Summary of Product Characteristics. June, 2020 for Enerzair.

6. Propeller Health^®, QR Rationale for EU Classification-2017-B 2019-07-24 Update.

7. Molimard M, et al. Eur Respir J. 2017;49:1601794.

8. Altman P, et al. BMC Pulm Med. 2018;18:100.